User contributions
Jump to navigation
Jump to search
- 00:16, 9 January 2020 diff hist +173 Olaparib (Lynparza) →gBRCAm Breast cancer
- 00:10, 9 January 2020 diff hist +196 Osimertinib (Tagrisso) →History of changes in FDA indication
- 00:07, 9 January 2020 diff hist +26 Panitumumab (Vectibix) →History of changes in FDA indication
- 00:03, 9 January 2020 diff hist +149 Panitumumab (Vectibix) →History of changes in FDA indication
- 00:00, 9 January 2020 diff hist +701 Pembrolizumab (Keytruda) →History of changes in FDA indication
- 23:32, 8 January 2020 diff hist +182 Ponatinib (Iclusig) →History of changes in FDA indication
- 23:18, 8 January 2020 diff hist +91 Rucaparib (Rubraca) →History of changes in FDA indication
- 23:14, 8 January 2020 diff hist +141 Trametinib (Mekinist) →History of changes in FDA indication
- 22:58, 8 January 2020 diff hist +104 Vemurafenib (Zelboraf) →History of changes in FDA indication
- 22:46, 8 January 2020 diff hist +39 Venetoclax (Venclexta) →Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
- 22:42, 8 January 2020 diff hist +24 Venetoclax (Venclexta) →Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
- 22:40, 8 January 2020 diff hist +24 Venetoclax (Venclexta) →History of changes in FDA indication